Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 27, 2015 9:32 AM ET


Company Overview of Ironwood Pharmaceuticals, Inc.

Executive Profile

Edward P. Owens CFA

Director and Member of Compensation & HR Committee, Ironwood Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 4 different industries.

See Board Relationships


Mr. Edward P. Owens, also known as Ed, CFA, served as a Partner, Senior Vice President, Portfolio Manager, and Global Industry Analyst at Wellington Management Company, LLP until December 2012. Mr. Owens joined Wellington Management Company, LLP in 1974 as a Healthcare Analyst. He served as Partner, Senior Vice President, Portfolio Manager, and Global Industry Analyst of Astra Funds - Astra Renaissance Global Health Care Fund and Vanguard Health Care Fund; Ecoflex Investment ...

Corporate Headquarters

301 Binney Street
Cambridge, Massachusetts 02142

United States

Phone: 617-621-7722
Fax: 617-494-0480

Board Members Memberships

Director and Member of Compensation & HR Committee


University of Virginia
Harvard Business School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Calculated Compensation$385,812

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Michael W. Aguiar Chief Executive Officer, President and Director
Theravance Inc.
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
Peter S. Greenleaf Chief Executive Officer and Director
Sucampo Pharmaceuticals, Inc.
A. J. Kazimi MBAFounder, Chairman, Chief Executive Officer, President and Principal Financial Officer
Cumberland Pharmaceuticals, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ironwood Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at